Psoriasis Global Market Report 2023 – By Drug Clas Psoriasis Global Market Report 2023 – By Drug Class (Interleukin Inhibitors, Corticosteroids, AntiInflammatory, Tumor Necrosis Factor Inhibitor), By Drug Types (Small molecules, Biologics), By Disease Indication (Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis), By Distribution Channel (Hospitals, Retail Pharmacies, ECommerce) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Psoriasis refers to a skin condition that typically affects the knees, elbows, trunk, and scalp and results with a rash with itchy, scaly spots. The primary contributing factor may be an immune system issue wherein infection-fighting cells unintentionally kill healthy skin cells. For further insights on the psoriasis market, request a sample here

The psoriasis market growth is aided by rise in the prevalence of psoriasis patients. However, some psoriasis market restraints include high cost of psoriasis therapy. For further insights on the psoriasis market, request a sample here

The psoriasis market is expected to reach $34.50 billion in 2027 at a rate of 10.9%. For further insights on the psoriasis market, request a sample here

The global psoriasis market is segmented as
1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce
3) By Drug Types: Small molecules, Biologics  
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
For further insights on the psoriasis market, request a sample here

North America was the largest region in the psoriasis market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the psoriasis market are, AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company., Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co, Inc., Janssen Biotech, Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca, UCB, Sun Pharmaceutical Industries Ltd, Forward Pharma, Almirall, Valeant Pharmaceuticals, Biogen Idec, Biocon, Celltrion Inc., Dr.Reddy's Laboratories. For further insights on the psoriasis market, request a sample here.

Major trends influencing the psoriasis market include combination therapy. Combination therapy is an f treatment that combines two different psoriasis treatments at the same time. When two drugs with different mechanisms of action are combined (combination therapy), the effect is greater than that obtained by monotherapy (treatment with a single drug). Studies suggest that combination therapy eases psoriasis symptoms more effectively than a single therapy and has lesser side effects. For further insights on the psoriasis market, request a sample here.

For detailed insights on the major opportunities and strategies in the psoriasis market, request a sample here.

For detailed insights on psoriasis market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the psoriasis industry, request a sample here.

For detailed insights on the key dynamics influencing the psoriasis market growth and SWOT analysis of the psoriasis industry, request a sample here.